Show simple item record

Urological Cancer 2020

dc.contributor.editorLópez, José I.
dc.date.accessioned2022-01-11T13:41:03Z
dc.date.available2022-01-11T13:41:03Z
dc.date.issued2021
dc.identifierONIX_20220111_9783036502700_489
dc.identifier.urihttps://directory.doabooks.org/handle/20.500.12854/76754
dc.description.abstractThis Urological Cancer 2020 collection contains a set of multidisciplinary contributions to the extraordinary heterogeneity of tumor mechanisms, diagnostic approaches, and therapies of the renal, urinary tract, and prostate cancers, with the intention of offering to interested readers a representative snapshot of the status of urological research.
dc.languageEnglish
dc.subject.classificationthema EDItEUR::G Reference, Information and Interdisciplinary subjects::GP Research and information: generalen_US
dc.subject.classificationthema EDItEUR::P Mathematics and Science::PS Biology, life sciencesen_US
dc.subject.otherrenal cell carcinoma
dc.subject.otheriron
dc.subject.othermacrophages
dc.subject.otherchelation therapy
dc.subject.otherurothelial carcinoma
dc.subject.othertranscriptome
dc.subject.othermicrotubule
dc.subject.otherMAP1B
dc.subject.otherprognosis
dc.subject.otherKLF5
dc.subject.otherandrogen receptor
dc.subject.othercell proliferation
dc.subject.othertumorigenesis
dc.subject.otherprostate cancer
dc.subject.otherprecision medicine
dc.subject.otherwhole genome sequencing
dc.subject.otheroptical mapping
dc.subject.othertherapy
dc.subject.otherprostate carcinoma
dc.subject.otherprostate mpMRI
dc.subject.othermachine learning
dc.subject.otherartificial intelligence
dc.subject.otherdeep learning
dc.subject.otherneural network
dc.subject.otherangiogenesis
dc.subject.otherangiogenic growth factors
dc.subject.otherantiangiogenic therapy
dc.subject.otherrenal tumors
dc.subject.otherprevention
dc.subject.otherα1-adrenoceptor antagonists
dc.subject.otheranoikis
dc.subject.othervascularity
dc.subject.otherresearch model
dc.subject.otheroncogenes
dc.subject.othertumor suppressor genes
dc.subject.otherMR-guided
dc.subject.otherradiotherapy
dc.subject.otherMRgRT
dc.subject.otherstereotactic ablative radiotherapy
dc.subject.otherstereotactic ablative radiation therapy (SABR)
dc.subject.otherrenal cell cancer
dc.subject.otherRCC
dc.subject.otheronline adaptive
dc.subject.other[68Ga]Ga-PSMA PET/CT
dc.subject.otherdual-time point imaging
dc.subject.otherdelayed imaging
dc.subject.otherbiphasic imaging
dc.subject.otherlesion positivity rate
dc.subject.otherCXCL9
dc.subject.otherPD1
dc.subject.otherPD-L1
dc.subject.otherstage T1 NMIBC
dc.subject.otherprostatic neoplasms/mortality
dc.subject.otherprostatic neoplasms/epidemiology
dc.subject.otherSEER Program
dc.subject.otherbladder cancer
dc.subject.othertransurethral resection
dc.subject.otheren-bloc resection
dc.subject.otherCPT1A
dc.subject.otherfatty acids
dc.subject.otherserine
dc.subject.otherandrogen response
dc.subject.otherROS
dc.subject.otheroxidative stress
dc.subject.otherDONSON
dc.subject.otherDownstream Neighbor of SON
dc.subject.otherbiomarker
dc.subject.othermetastatic spread
dc.subject.otherdiagnosis
dc.subject.otherdifferential diagnosis
dc.subject.otherhistopathology
dc.subject.otherimmunohistochemistry
dc.subject.otherstroma signature
dc.subject.otherpatient-derived xenografts
dc.subject.othern/a
dc.titleUrological Cancer 2020
dc.typebook
oapen.identifier.doi10.3390/books978-3-0365-0271-7
oapen.relation.isPublishedBy46cabcaa-dd94-4bfe-87b4-55023c1b36d0
oapen.relation.isbn9783036502700
oapen.relation.isbn9783036502717
oapen.pages334
oapen.place.publicationBasel, Switzerland


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0/
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0/